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Differential expression of p120-
catenin 1 and 3 isoforms in 
epithelial tissues
Jan-Hendrik Venhuizen1, Sebastian Sommer1, Paul N. Span2, Peter Friedl1,3,4 & 
Mirjam M. Zegers  1
P120 catenin (p120) is a non-redundant master regulatory protein of cadherin-based cell-cell junctions, 
intracellular signaling, and tissue homeostasis and repair. Alternative splicing can generate p120 
isoforms 1 and 3 (p120-1 and p120-3), which are implicated in non-overlapping functions by differential 
expression regulation and unique interactions in different cell types, with often predominant expression 
of p120-1 in mesenchymal cells, and p120-3 generally prevalent in epithelial cells. However, the lack 
of specific p120-3 protein detection has precluded analysis of their relative abundance in tissues. 
Here, we have developed a p120-3 isoform-specific antibody and analyzed the p120-3 localization 
relative to p120-1 in human tissues. p120-3 but not p120-1 is highly expressed in cell-cell junctions of 
simple gastrointestinal epithelia such as colon and stomach, and the acini of salivary glands and the 
pancreas. Conversely, the basal layer of the epidermis and hair follicles expressed p120-1 with reduced 
p120-3, whereas most other epithelia co-expressed p120-3 and p120-1, including bronchial epithelia 
and mammary luminal epithelial cells. These data provide an inventory of tissue-specific p120 isoform 
expression and suggest a link between p120 isoform expression and epithelial differentiation.
Cadherins are transmembrane cell-cell adhesion receptors with crucial roles in development, morphogene-
sis, tissue homeostasis and cancer. A key regulator of cadherin function is p120 catenin (p120), an armadillo 
(ARM)-related protein, which controls the retention and stability of classical cadherins at the plasma membrane 
by binding directly to the cytoplasmic tail of cadherins1. Besides cell-cell interactions, p120 regulates gene tran-
scription through several transcription factors including Kaiso2, and the activity of Rho family GTPases and 
downstream cytoskeletal dynamics. In mice, germline deletion of p120 is embryonic lethal3,4, suggesting critical 
and non-redundant functions, and conditional deletion of p120 using the Cre/LoxP system causes early lethal-
ity or dramatic developmental defects in epithelial and endothelial tissues such as the vasculature5, colon and 
intestine6, salivary gland7, mammary gland8,9 and the proximal tubules of the kidney10. Deletion of p120 further 
leads to inflammation in the skin, the intestinal tract, pancreas and lung6,11–15 as well as tumor initiation or pro-
gression in epithelial organs, including salivary gland7, skin11,12, esophagus14, mammary gland9 and liver16. The 
severity and variability of these outcomes is tissue-dependent and may depend on the level and type of cadherins 
expressed and co-expressed p120 family members, such as ARVCF, δ-catenin, p0071, and plakophilins 1–33.
An additional important but poorly understood level of regulation of p120-dependent cell- and tissue func-
tions depends on differential expression of p120 isoforms generated from its single CTNND1 gene. Alternative 
splicing-dependent use of four different translation initiation sites results in p120 isoforms 1, 2, 3 and 4 (p120-1-4)17,18. 
The longest isoform p120-1 contains a 101 amino acid N-terminal domain including a coiled-coil motif which is 
lacking in p120-3. Since p120-1 and p120-3 have differential affinities for binding partners, including transcrip-
tion factors such as Kaiso and DIPA2,19 and regulators of Rho GTPase signaling20, their differential expression 
patterns likely reflect functional differences, including opposing effects of p120 isoforms on proliferation and cell 
migration21–24. Therefore, a detailed analysis of p120 isoform expression in situ in human tissues is of interest. 
Previous analyses by Western blot18, whole-tissue RT-PCR analysis17 and, indirectly, by immunofluorescence 
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in tissues using p120-1-specific and pan-p120 antibodies25, have indicated that most cells express multiple p120 
isoforms, with p120-3 often prevalent in differentiated epithelial cells, in combination with variable expression 
of p120-1. However, the direct detection of p120-3 localization in tissues at the cellular level is precluded by the 
lack of a p120-3-specific antibody. As technical challenge, compared to p120-1, p120-3 lacks a unique amino acid 
sequence, and this has complicated the development of selective antibodies.
Here, we describe the development of polyclonal p120-3-specific antibodies using a strategy that uses the free 
N-terminal amino acid as a unique epitope of p120-3. Using this antibody together with a commercial p120-
1-specific monoclonal antibody, we directly compare expression and localization of p120 isoforms in human epi-
thelial and non-epithelial tissues by immunofluorescence. We show that whereas p120-3 expression is generally 
associated with E-cadherin expression, several E-cadherin-positive epithelial cells express p120-1 as the domi-
nant form, particularly epithelial compartments with a lower differentiation state or high turnover, such as the 
basal layer of the skin and bronchial epithelia. In addition, differential p120-1 and p120-3 expression is detected 
in distal and proximal tubuli of the kidney, and p120-3, but not p120-1 is absent from non-epithelial tissues. These 
data for the first time directly compare p120 isoform expression in human tissues, and suggest a link between 
p120 isoform expression and differentiation state.
Materials and Methods
Immunogen design. A distinct chemical difference between p120-3 and p120-1 is the presence of a free 
amino acid at the N-terminus of p120-3 whereas a peptide bond is present at the corresponding amino acid in 
p120-1 (Fig. 1A). We therefore used the N-terminus of p120-3 as a unique epitope for specific antibody devel-
opment. The first ten amino acids corresponding to the human p120-3 N-terminus show 100% homology to the 
N-terminal amino acid sequence of p120-3 in mouse and dog (UniGene, NCBI), and were selected as antigen 
(Fig. 1A). Cleavage of the initiator methionine and/or N-terminal acetylation are processes that may occur in over 
50% of eukaryotic proteins26, but it is unknown whether the p120-3 N-terminus is subject to these modifications. 
We therefore combined four different peptides representing the four possible N-termini (peptides 1–4, Fig. 1B) 
of p120-3, for immunization.
Generation and purification of p120-3-specific antibodies. Peptide synthesis, coupling to Keyhole 
Limpet Hemocyanin (KLH), immunization, serum collection and automated affinity chromatography were per-
formed by ImmunoGlobe GmbH, Germany. Briefly, peptides representing p120-3 N-termini (Fig. 1A,B) were 
synthesized with purity >98%, except for p120-3 peptide 1. The free N-terminal glutamyl residue of this peptide 
was subject to pyroglutamyl formation, as occurs in vivo27, resulting in a purity of 76.8% with a 22.5% contribu-
tion of the pyroglutamyl form. The identity of the peptides was confirmed by mass spectrometry. An equimolar 
mix of p120-3 peptides 1–4 was conjugated to KLH via an extra C-terminal cysteine residue. Two female rabbits 
aged six and nine months of a proprietary strain were immunized intradermally with the KLH conjugate in PBS 
containing on average 117 μg of each of the four peptides, emulsified 1:1 with complete Freund’s adjuvant. The 
rabbits were boosted with half that dose, each, after 2, 4, 8, 10, 12, 28, 31, and 35 weeks, with Montanide ISA 206 
as an adjuvant and in week 33 with antigen emulsified in Montanide ISA 50V2. Test sera were taken after week 6, 
aimed at characterizing antibodies targeting the different potential N-termini. Regular sera were collected 14, 16, 
18, 37, 39, and 41 weeks after the first immunization.
For affinity purification, individual peptides were conjugated via the C-terminal cysteine residue to Sulfolink 
Iodoacetyl resin (ThermoFischer). For initial proof-of-concept experiments, test sera taken at week 6 after initial 
immunization were affinity purified on a tandem array of five columns, with the p120-1 peptide matrix com-
prising an immobilized peptide corresponding to amino acids P100 - T111 of the p120-1 sequence, followed 
by matrices with p120-3 peptides 1 to 4 in the indicated order (Supplementary Fig. 1). Total yields of the differ-
ent affinity-purified fractions showed that in either rabbit over 80% of antibody was recovered from the p120-1 
peptide column (Rb1-p120, Rb2-p120), indicating that the majority of the raised anti-p120 antibodies did not 
specifically recognize the free N-terminus of p120-3 (data not shown).
To prepare the final anti-p120-3 antibodies, which was used for all stainings, regular sera were pooled, diluted 
in PBS, and antibodies cross-reacting with p120-1 were depleted by multiple adsorption/elution cycles on the 
p120-1 peptide matrix until no protein in the eluate was detected. Next, p120-3-specific antibodies were affin-
ity purified on a resin with p120-3 peptide 2, the eluate was dialyzed to PBS, and passed again over the p120-1 
peptide matrix for additional depletion of potentially remaining p120-1 cross-reacting antibodies. The resulting 
antibody was quantified photometrically (1.4 OD280 ≙ 1.0 mg/ml) and concentrated by ultrafiltration, stabilized 
with 1 mg/ml BSA and 0.02% NaN3, and sterile filtered.
Antibodies and fluorescent dyes. In addition to the p120-3 isoform-specific rabbit polyclonal antibodies 
described in this work, antibodies against p120 included mouse monoclonal p120, clone 98 (p120 mAb (98), 
BD Biosciences cat no. 610134), which recognizes all p120 isoforms, and 6H11 (Santa Cruz sc-23873), a mouse 
monoclonal antibody against p120-1 and p120-228, which in most tissues recognizes a single isoform correspond-
ing with p120-1 on Western blot (WB)25. Rabbit polyclonal p120-3 antibodies and the Rb1- and Rb2-p120 were 
diluted to 1 µg/ml for WB, 1.5 µg/ml for immunofluorescence (IF) of cells and 5 µg/ml for IF of tissues, p120 
mAb (98) was used 0.25 µg/ml for WB and 0.5 µg/ml for IF and 6H11 was used 4 µg/ml for IF. Additional anti-
bodies used in this study are: CD34 (Abcam Ab8536, 1.33 µg/ml for IF), Vimentin (Abcam 24525, diluted 1:400 
for IF), wide spectrum Cytokeratin (PCK, Abcam Ab9377, diluted 1:200 for IF), E-cadherin (BD Biosciences 
610182, 2.5 µg/ml in IF), and E7 mouse monoclonal anti-β-tubulin (Developmental Studies Hybridoma Bank, 
University of Iowa, USA) was used as a loading control for WB. Secondary antibodies for Odyssey detection com-
prised Alexa Fluor 680-conjugated or Alexa Fluor IRDye 800-conjugated goat anti-mouse and goat anti-rabbit 
IgG (Invitrogen). To visualize nuclei and F-actin, 4′,6-Diamidine-2′-phenylindole dihydrochloride (DAPI, Roche 
www.nature.com/scientificreports/
3SCIeNTIfIC RepoRts |            (2019) 9:90  | DOI:10.1038/s41598-018-36889-w
10236276001, 5 µg/ml) and Alexa Fluor™ 488-conjugated Phalloidin (ThermoFischer, 1:200) were used, respec-
tively. Secondary antibodies for immunolabeling of cells and tissues comprised Alexa Fluor™ 546 or 647 goat 
anti-mouse IgG (H + L), Alexa Fluor™ 488, 546 or 647 goat anti-rabbit IgG (H + L), Alexa Fluor™ 488 goat 
anti-chicken IgY (H + L) and Alexa Fluor™ 555 donkey anti-rabbit IgG (H + L) conjugates (Invitrogen).
Cell culture. MDCK parental, p120 knock-down and murine p120 re-expression cell lines were a generous 
gift from A. Reynolds29, and were grown in MEM (Gibco) supplemented with 10% FCS, 10.000 U/ml penicillin/
streptomycin and 2 mM L-glutamine at 37 °C, 5% CO2. NMuMG cells were grown in DMEM, supplemented with 
10% FCS, 10.000 U/ml penicillin/streptomycin, 2 mM L-glutamine and 10 µg/ml insulin at 37 °C, 10% CO2. 4T1 
cells were grown in RPMI 1640 (Gibco) supplemented with 10% FCS, 10.000 U/ml penicillin/streptomycin and 
1 mM sodium pyruvate at 37 °C, 5% CO2.
Generation of 4T1 p120 KO cells by CRISPR/Cas9. 4T1 cells were transfected using Lipofectamine 
2000 (Invitrogen) 24 hours after plating with 2 µg of a pool of three p120 CRISPR Cas9 KO constructs. 
Each of these constructs encodes a Cas9 nuclease and GFP driven by a chicken β-actin hybrid promoter, 
and one of the following gRNAs under the control of a U6 promoter, and derived from the GeCKO v2 
library: gRNA1 TCTGGTCCGATTGCTCCGAA, gRNA2 TGTGGTCTCCGTGCGTCTAG, gRNA3 
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Figure 1. Generation and characterization of p120-3-selective pAb: strategy and specificity testing. (a) Domain 
structure and antibody recognition sites of p120 isoforms. p120 consists of an N-terminal region (NTR), 
an Armadillo (ARM) domain and a C-terminal region (CTR). Alternative entry points (corresponding to 
methionines at amino acid positions 1, 55, 102 and 324 for p120-1) lead to protein isoforms differing in the 
NTR. Established monoclonal antibodies target the N-terminus of p120-1 and p120-2 (6H11) or the ARM 
domain (p120 mAb (98)). Alignment of human, murine and canine sequences from the NCBI database show 
that the p120-3 N-terminus, starting with the methionine (m) indicated in grey shading, is highly conserved. 
(b) In green, peptides designed to represent different potential p120-3 N-termini, modified by acetylation 
and/or methionine cleavage are indicated (p120-3 peptide 1–4). The blue-shaded top row shows the p120-1 
peptide, which includes the two amino acids (PR) directly preceding the p120-3 initiator methionine. (c) After 
immunization with the peptide 1–4 mix, the sera of the two rabbits were pooled and depleted for anti-p120-1 
antibodies by passing them several times over the p120-1 column (blue). Upon p120-1 depletion, anti-p120-3 
was purified by affinity purification using immobilized p120-3 peptide 2 (green). (d) Western blot analysis of 
4T1 cells expressing endogenous p120 (ctrl) and 4T1 p120 knock-out cells (p120KO). The Western blots were 
incubated with either p120 mAb (98), which recognizes all p120 isoforms, or anti-p120-3 (indicated below each 
blot). Full length blots are shown in Supplementary Fig. 13. (e) Immunofluorescence of 4T1 ctrl and p120KO 
with anti-p120-3. (f) Immunofluorescence of an FFPE section of a human mammary gland using 6H11 and 
anti-p120-3. An adjacent section was incubated with species-matched non-targeting control IgGs (Ms-IgG and 
Rb-IgG).
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TGATGGGACCACTAGACGCA targeting three different sites in the Ctnnd1 gene (Santa Cruz sc-419478). As 
a control, cells were transfected with a non-targeting scrambled gRNA construct (Santa Cruz sc-418922). Media 
were changed 6 h after transfection, and after growth for an additional 72 h in antibiotics-free medium, single 
GFP-expressing cells were collected in a 96 wells plate using a DB Aria flow cytometry sorter and grown for 3 
weeks until colonies appeared. P120 KO colonies were selected after 3 weeks based on Western blot analysis.
Western blot analysis. Cells grown for 48 h to 95% confluence in 6 well plates were washed once with PBS 
prior to lysis. Subsequently, cells were scraped in Laemlli sample buffer (100 mM Tris-HCl, 4% SDS, 20% glycerol, 
200 mM DTT, bromophenol blue) and proteins were denatured by heating at 95 °C for 5 minutes.
Proteins were separated by SDS-PAGE and transferred to PVDF membrane. Membranes were blocked with 
5% BSA in PBS with 0.2% Tween-20 (PBST) and incubated overnight at 4 °C with primary antibodies in 5% BSA 
in 0.2% PBST. The membranes were subsequently washed six times with 0.2% PBST and incubated with Alexa 
Fluor-conjugated secondary antibodies (Thermo Fischer) for 1 h at room temperature. The blots were washed 
six times with 0.2% PBST and once in PBS. The blots were scanned using the Odyssey CLx imaging system 
(Li-Cor, Lincoln, NE) and analyzed with the Image Studio Lite software Ver 4.0. Uncropped blots are shown in 
Supplementary Fig. 13.
Immunofluorescence of cultured cells. Cells grown for 48 h on coverslips were fixed for 15 min at 37 °C 
with 4% paraformaldehyde in 0.1 M phosphate buffer pH 7.4. After blocking with 10% normal goat serum and 
0.3% Triton X-100, cells were incubated with primary antibody for 2 h at room temperature, and subsequently 
with Alexa Fluor-conjugated secondary antibodies (Thermo Fischer), DAPI and Alexa Fluor™-conjugated phal-
loidin (ThermoFischer) to visualize nuclei and F-actin, for 1 h at room temperature. Coverslips were mounted on 
object slides with FluorSave (Calbiochem), and cells were imaged with a Leica DMI6000B using a HC PL APO 
63x oil objective and DFC365FX camera. Confocal imaging was performed with a Fluoview FV1000 microscope 
(Olympus) using a LUMPLFL 40x water objective.
Immunoprecipitation of p120 isoforms. Cells grown for 72 h to 100% confluence in 10 cm dishes were 
washed twice with ice-cold PBS prior to lysis on ice with 1 ml IP lysis buffer (125 mM NaCl, 20 mM Hepes pH 
7.4, 1% Nonidet P40 substitute, 5 µg/ml pepstatin, 10 µg/ml chymostatin, 3 µg/ml leupeptin, 10 µg/ml antipain, 
0.5 mM benzamadin, 0.2 mM PMSF, 0.1 kU/ml aprotinin, 1 mM Na3VO4, 1 mM NaF). Insoluble debris was 
removed by centrifugation for 15 min at 15,000 g, 4 °C. Lysates were precleared with CL-4B beads (GE Healthcare, 
Piscataway, NJ) for 30 min at 4 °C. As total lysate control, 5% of the cleared lysate was used. The remaining super-
natant was incubated with 1-2 µg of antibody for 1 h at 4 °C. Sepharose-Protein G was added and the lysates were 
incubated overnight at 4 °C while rotating. The beads were washed five times with lysis buffer by centrifugation. 
Proteins were eluted from the beads by heating for 5 minutes in sample buffer with 100 mM DTT at 95 °C and 
the samples were, together with the lysates (5% of total), analyzed by SDS-PAA gel electrophoresis and Western 
blotting
Human tissues. 4 µm tissue sections of human kidney were provided by the department of Pathology, 
Radboud university medical center Nijmegen. These samples comprised anonymised left-over tissue from rou-
tine treatment at our Academic Hospital, used with permission of the IRB of the Radboudumc according to 
national law and the Code of Conduct of the Federation of Medical Scientific Societies in the Netherlands (Code 
for Proper Secondary Use of Human Tissue in the Netherlands). Only tissues from patients that did not object to 
the use of their biomaterials for academic research were used. Tissue samples from the human mammary gland 
comprised normal tissue of breast cancer patients adjacent to tumor tissue. These tissues were obtained, with 
informed consent, from the Radboud Breast Cancer Biobank, approval 2013/576 IRB (Institutional review board) 
Radboud university medical center. All other tissue samples were from a commercial human tissue microarray 
containing 23 × 2 mm cores (Bio SB; bsb0298).
Haematoxylin and eosin (H&E) staining of formalin-fixed tissue. Formalin-fixed 
paraffin-embedded (FFPE) tissue sections were deparaffinized by incubating sequentially three times for 5 min in 
xylene, and subsequent incubations in 100%, 96%, 70% and 50% ethanol and distilled water, each twice for 1 min. 
Next, the sections were incubated with haematoxylin for 20 min. The samples were washed for 15 min in running 
water, and subsequently incubated 5 min with eosin. The samples were washed briefly in water, and dehydrated by 
sequentially incubating twice for 1 min in 50%, 70%, 96% and 100% ethanol, and three times 1 min in xylene. The 
sections were imaged using the Pannoramic Flash 250III (3D Histech), using a Plan-Apochromat 20x objective 
and a CIS VCC-FC60FR19CL camera.
Immunofluorescence of formalin-fixed tissue. 4 µm thick FFPE tissue sections were deparaffinized by 
incubating sequentially three times for 5 min in xylene, twice 5 min in 100% and 96% ethanol, 1 min in 70% and 
50% ethanol, and 10 min in flowing distilled water. Subsequently, antigen retrieval was performed by incubating 
15 min in Tris-EDTA buffer (10 mM Tris, pH 9.0, 1 mM EDTA) heated to 95 °C. Samples were allowed to cool 
for 1 h at room temperature, washed with PBS for 1 h, and blocked with 10% normal goat serum, 1% BSA and 
0.2% Triton X-100 in PBS. The sections were incubated with primary antibody overnight at 4 °C in 1% BSA/ 
0.05% PBST, and with Alexa Fluor-conjugated secondary antibodies and DAPI in the same buffer for 1 h at room 
temperature. As a negative control, an adjacent tissue section was incubated with species-matched non-targeting 
(NT) primary IgGs. Antibody incubation steps were followed by washing three times 5 min with 0.05% PBST. 
Coverslips were mounted onto the sections with Fluoromount-G (ThermoFischer). The sections were imaged 
using the Pannoramic Flash 250III (3D Histech), using a Plan-Apochromat 20x objective and a pco.edge 5.5 
4MP camera, the DMI6000B (Leica) using an HCX PL S-APO 20.0 × 0.50 DRY objective or an HCX PL S-APO 
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40.0 × 0.75 DRY objective with a DFC360FX camera, or the Fluoview FV1000 (Olympus) with a UPLSAPO 60x 
oil objective.
Results
Validation of the anti-p120-3 purification protocol. To validate our approach towards purification of 
p120-3 antibodies two rabbits were immunized with a mix of four peptides representing differentially modified 
p120-3 N-termini (Fig. 1A,B). An aliquot of serum of either rabbit was depleted of antibodies recognizing p120-1, 
and p120-3-recognizing antibodies were subsequently isolated from the p120-1-depleted antiserum by sequential 
affinity purification using immobilized p120-3 peptides 1–4 (Supplementary Fig. 1). The performance and speci-
ficity towards p120-3 of the resulting eight antibody fractions as analyzed by Western blot, immunoprecipitation 
and immunofluorescence was variable (Supplementary Fig. 1 and data not shown). As unexpected result, we 
found that all antibody fractions recognized p120-3 in an assay in which we immunoprecipitated p120-3 with 
one antibody followed by detection with each other antibody fraction (data not shown), or with a anti-p120 mon-
oclonal recognizing all isoforms (Supplementary Fig. 1) indicating that the different N-termini of p120-3 species 
were not recognized differentially.
Purification and characterization of anti-p120-3 antibody. To improve the yield of anti-p120-3 
antibody with highest possible specificity, we selected immobilized peptide 2 as the single affinity column to 
purify-p120-3 from p120-1-depleted serum, based on a strong detection of p120-3 and a lack of cross-reactivity 
with p120-1 in all three techniques used in either rabbit. To further minimize cross-reactivity to p120-1 and 
increase recognition of p120-3, additional immunizations were administered to the rabbits. Next, antibodies 
recognizing p120-1 were depleted from pooled rabbit sera by multiple depletion rounds with a p120-1 peptide 
column, followed by affinity purification using immobilized peptide 2 (Fig. 1C). The resulting antibody fraction 
(“anti-p120-3”) was used in all subsequent experiments.
Anti-p120-3 specifically detected p120-3 by Western blotting as shown using lysates of wild-type 4T1 murine 
mammary cancer cells and 4T1 p120 KO cells generated by CRISPR/Cas9-mediated knock-out of Ctnnd1 
(Fig. 1D). Immunoblotting of anti-p120-3 immunoprecipitates showed detection by all previously generated 
fractions from the peptide 1–4 affinity columns (Supplementary Fig. 2), indicating that anti-p120-3 recognizes 
the total cellular pool of p120-3. Immunofluorescence labeling of 4T1 control and 4T1 KO cells also demon-
strated specific staining (Fig. 1E). To determine its suitability for application in FFPE human tissue, anti-p120-3 
was applied in routine histological samples and compared to binding of mouse anti-p120-1 monoclonal anti-
body 6H1128. Both antibodies strongly labeled the membrane of mammary epithelial cells, compared to dif-
fuse low-level background signal obtained by species-matched non-targeting IgG (Fig. 1F). A strong signal for 
anti-p120-1, but not anti-p120-3, was observed in capillaries, larger blood vessels and the glomerulus of the 
kidney, and occasionally in stromal cells (Supplementary Figs 3 and 4), consistent with previous reports25. Thus, 
anti-p120-3 antibody recognizes murine and human p120-3, does not cross-react with p120-1, and can be applied 
in analyses by Western blot, immunoprecipitation and immunofluorescence in cells and human FFPE tissue.
P120-1 and p120-3 expression in normal human tissues. Co-expression of p120-1 and p120-3 in cili-
ated pseudostratified epithelia but not in gastrointestinal simple epithelia. Gastrointestinal simple epithelia of the 
stomach and colon were identified to predominantly express p120-3, which showed a slightly increased intensity 
along the plasma membrane at the base and apex, in colocalization with E-cadherin (Fig. 2, arrowheads). Staining 
of p120-1 was below the detection limit in these epithelia but blood vessels from the same sections were positive 
for p120-1 (Supplementary Fig. 5), indicating that low p120-1 staining was not due to technical issues. In contrast 
to colon and stomach, p120-1 strongly stained the pseudostratified ciliated epithelia of the fallopian tube and 
bronchus, which co-expressed p120-3 and p120-1 along the entire lateral surface from apex to base (Fig. 2). Thus, 
in these examples of simple and pseudostratified epithelia we found consistent co-expression of E-cadherin and 
p120-3, whereas levels of p120-1 are variable. The differential detection of both isoforms in different tissues fur-
ther emphasizes the selectivity of anti-p120-3 antibodies for analysis of archival FFPE material.
p120-1 is co-expressed with p120-3 in ducts but not acini of glandular epithelia. Differential expression of p120 
isoforms was further detected in the ducts and acini of glandular tissue of the pancreas, parotid salivary gland and 
prostate gland (Fig. 3, Supplementary Fig. 6). Acinar epithelial cells of these tissues expressed p120-3, with low 
or no p120-1 and pan-cytokeratin (PCK) expression as detected by a broad spectrum antibody that reacts with a 
variety of epithelial cell types (Fig. 3, open arrowheads). By contrast, the ductal compartment of the pancreas and 
salivary gland co-expressed p120-3 and p120-1 (Fig. 3, closed arrowheads; Supplementary Fig. 6). Both glandular 
and ductal epithelia expressed E-cadherin expression at similar levels.
The glandular tissue derived from ectodermal appendages, including sweat glands and the mammary gland30, 
co-expressed both p120-1 and p120-3, in addition to E-cadherin and PCK (Supplementary Fig. 7). At subcellular 
resolution, p120-1 and p120-3 localized to both lateral and basal plasma membrane of mammary epithelial cells 
(Supplementary Fig. 7), indicating coexistence of both p120 isoforms along both adhesions between luminal cells 
and adhesions between luminal cells and the myoepithelial layer.
Differential expression of p120-1 and p120-3 in kidney tubules. The different segments of the kidney tubules 
differentially express p120 isoforms. Distal tubules predominantly expressed p120-3, with low or no p120-1, 
whereas proximal tubules expressed p120-1, with very low p120-3 (Fig. 4). N- and E-cadherin expression was 
reported to segregate to proximal and distal tubules of the human kidney, respectively31 and the different p120 
isoform expression may reflect differential engagement in epithelial- or mesenchymal-type adherens junctions18. 
Consistently, E-cadherin and PCK were expressed in distal but not in proximal tubules (Fig. 4).Taken the results 
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in simple and pseudostratified epithelia together, although p120-3 often associates with E-cadherin expression, 
the link between p120-1  and E-cadherin is more variable.
Differential expression of p120-1 and p120-3 within stratified epithelia. p120-3 was strongly expressed in all epi-
thelial cells of the epidermis, hair follicles and sebaceous glands, together with E-cadherin and PCK, but intensity 
was reduced in the basal layer (Fig. 5, Supplementary Fig. 8). p120-1 showed comparably inverse expression, 
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Figure 2. p120 isoform localization in simple and pseudostratified epithelia. Panels show p120-1 (6H11 
mAb) and p120-3 (anti-p120-3 pAb) expression in the colon, stomach, fallopian tube and bronchus, and PCK, 
E-cadherin and H&E in adjacent sections. Open and filled arrowheads indicate apical (filled, apex) and basal 
(open, base) subregions of the epithelial cell-cell adhesion.
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with peak intensity in basal compartments and no signal in upper epithelial layers. Occasional vimentin- and 
p120-1-positive cells were observed within the upper layers, likely representing intraepidermal Langerhans cells32 
(Fig. 5, Supplementary Fig. 8). The p120-1-positive basal epithelial cells, including the basal layer of the epider-
mis, the outer root sheath of the hair follicle and cells covering the sebaceous gland contain multipotent precursor 
cells33, thus suggesting a switch from p120-1 to p120-3 expression with epidermal differentiation. Differential 
p120-1 and p120-3 expression was further detected in basal and stratified cells of tonsil but not cervix epithelium 
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Figure 3. p120 isoform localization in glandular tissue. Panels show p120-1 (6H11 mAb) and p120-3 
(anti-p120-3 pAb) expression in the pancreas and a salivary gland, and vimentin, PCK and E-cadherin and 
H&E in adjacent sections. Open and filled arrowheads indicate ducts (filled) and glandular acini (open). Lower 
panels are magnifications of the area indicated by the dashed boxes.
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(Supplementary Fig. 9). This indicates that p120-3 is largely absent in the stem-cell-containing basal layer but is 
upregulated with stratification of multilayered epithelia33.
p120-3 expression in the liver is restricted to the bile duct. In the liver, co-expression of p120-3, E-cadherin and 
PCK was restricted to the cholangiocytes of the bile ducts, which further lacked p120-1 (Supplementary Fig. 10). 
By contrast, both p120-3 and p120-1 were largely absent in hepatocytes, despite strong expression of E-cadherin 
(Supplementary Fig. 10).
p120-3 expression in other tissues. The densely T-cell-populated tissues of the thymus and tonsil showed spo-
radic punctate p120-1 distribution, and were negative for p120-3 and E-cadherin (Supplementary Fig. 11). 
Notably, p120-1 was enriched in the germinal centre, in a pattern that is reminiscent of (epithelio)reticulocytes34. 
E-cadherin and p120-3, but not p120-1, were further expressed in the junctions between the syncytiotroph-
oblasts that form a syncytium at the outer layer of the chorionic villus and cytotrophoblasts of the placenta 
(Supplementary Fig. 12). In the seminiferous tubule p120-1 was expressed in the vimentin-positive outer layer 
of spermatogonia, but gradually reduced towards the centre and completely absent in differentiated spermatids 
(Supplementary Fig. 12). P120-3 and E-cadherin were neither expressed in the testis nor neuronal tissue of the 
cerebellum (data not shown). Thus, p120-3 is mostly absent from non-epithelial tissues.
Discussion
Here we show that isoform-specific antibodies can be raised to p120-3 based on its N-terminus, despite its other-
wise identical amino acid sequence to p120-1. The direct co-labeling of both p120 isoforms provides complemen-
tary insights into p120 isoform expression, whereas previous studies relied on an indirect subtractive approach 
cross-referencing anti-p120-1 labeling against pan-p120 detection25,32.
We considered four different p120-3 N-termini that may arise due to cleavage of the initiator methionine, and/
or N-terminal acetylation26. All four antibody fractions recognized cell-derived p120-3, which suggests that the 
p120-3 antibody fractions raised against different N-terminal peptides are polyspecific. Specificity towards p120-3 
and not p120-1 may be due to sterical inability to accept the bulky charged arginine residue, located immediately 
N-terminally of the initiator methionine of p120-3 in the p120-1 polypeptide in the binding pocket35.
By immunolocalization analyses of both p120-1 and p120-3 in a sampling of mostly epithelial human tissues 
we confirm previously observed variance of p120-3 and p120-1 co-expression in different epithelia, as demon-
strated by protein or mRNA expression analyses or inferred by immunofluorescence17,25,36,37. Specifically, we 
show highly prevalent p120-3 expression in terminally differentiated cells including excretory glandular cells 
and non-basal epidermal cells, and in the stomach and colon in conjunction with E-cadherin-positive adherens 
junctions, the latter of which is in accordance with previous immunolabelings of other gastrointestinal epithe-
lia25. Preferential expression of p120-1 or co-expression of p120-3 and p120-1 is demonstrated in basal layers of 
epithelia of the skin and skin appendages including the hair follicle, sebaceous gland, sweat gland and mammary 
gland30, as well as in pseudostratified epithelia with high turnover, such as bronchial epithelium.
The relevance of varying co-expression of p120 isoforms is currently unclear. Differentiation and tissue 
homeostasis in many of the epithelia in which we find relative high p120-1 expression is controlled by canonical 
Wnt signaling including the skin, proximal kidney tubule, and fallopian tube38–41. P120 is structurally related to 
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β-catenin, a key regulator of the Wnt pathway3 and p120-1, but not p120-3, contains a Wnt signaling destruction 
sequence causing p120-1 stabilization in the presence of Wnt signaling42. Nuclear signaling by p120 isoforms 
has been implicated in canonical Wnt signaling by their ability to regulate Kaiso-mediated gene expression and 
controlling the expression of, and response to, Wnt ligands in conjunction with β-catenin43,44. These findings 
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Figure 5. p120 isoform localization in the skin. (a) Histological section of epidermis, containing a hair follicle 
and sebaceous glands. (b) p120-1 (6H11 mAb) and p120-3 expression (anti-p120-3 pAb) in the epidermis, the 
root sheath of a hair follicle and a sebaceous gland. Panels on the right represent a magnification of the area 
in the dashed boxes. Open and filled arrowheads indicate p120-1-positive cells in the basal layer (filled) and 
intermediate layers (open).
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suggest highly complex p120 isoform-dependent regulation of Wnt signaling. Future work will clarify whether 
high p120-1 expression is maintained through Wnt signaling in these tissues and the functional correlations 
between differential p120 isoform expression, Wnt signaling regulation and tissue homeostasis.
Application of direct p120-1 and p120-3 detection will be useful in understanding the tissue-specific func-
tions of p120 isoforms. Tissue-specific isoform expression patterns, and associated differential regulation of 
isoform-specific function likely underlie the highly variable phenotypes obtained in conditional knock-out stud-
ies in mice. While some mouse knock-out phenotypes, such as loss of epithelial integrity and resulting inflam-
matory responses likely depend on shared functions of p120 isoforms, in particular stabilization of cadherins5,6, 
other phenotypes may be due to isoform-specific functions. For example, ablation of p120 in the salivary gland7 
or pancreas15 results in reduced acinar differentiation and increased ductal content. The differential isoform 
expression in glandular ducts and acini may affect differentiation, for instance via Wnt signaling as discussed 
above. Similarly, the p120 knock-out-induced phenotype observed in proximal, but not distal tubules10, may be 
related to the different isoforms expressed in this tubular segments. Isoform-specific functions may also explain 
tissue-dependent susceptibility to oncogenic transformation upon p120 knock-out, as seen in salivary gland7, 
skin11,12 and the mammary gland9, which may be due to differences in nuclear signaling or cytoskeletal regulation.
The regulation of p120 isoform expression, for instance through ESRP1 and 245, and the functional signif-
icance of p120-3 and p120-1 expression in development and cancer warrants further work. Isoform-specific 
knock-out models based on removal of specific exons46 or targeted mutation of specific initiator methionines, 
may elucidate the extent of compensation and exclusive functions in an in vivo context.
Data Availability
The datasets generated and/or analyzed during the current study are available from the corresponding author on 
reasonable request.
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